Scarica l'app Stockscreener
69.14
2.03%
1.3555
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$67.78
Aprire:
$67.95
Volume 24 ore:
289.92K
Relative Volume:
0.26
Capitalizzazione di mercato:
$1.97B
Reddito:
$267.23M
Utile/perdita netta:
$-83.50M
Rapporto P/E:
-22.23
EPS:
-3.11
Flusso di cassa netto:
$-59.99M
1 W Prestazione:
+8.72%
1M Prestazione:
-28.62%
6M Prestazione:
-12.13%
1 anno Prestazione:
+245.97%
Intervallo 1D:
$67.00
$69.38
Intervallo di 1 settimana:
$63.15
$73.57
Portata 52W:
$19.16
$117.75
Genedx Holdings Corp Stock (WGS) Company Profile
Nome
Genedx Holdings Corp
Settore
Industria
Telefono
888-729-1206
Indirizzo
333 LUDLOW STREET, STAMFORD
Confronta WGS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
69.12 | 1.70B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
399.64 | 153.28B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
187.56 | 134.42B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
506.12 | 40.97B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
109.74 | 31.79B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
138.00 | 24.53B | 15.50B | 1.33B | 2.16B | 7.34 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-15 | Iniziato | Guggenheim | Buy |
| 2025-05-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-07-10 | Iniziato | Craig Hallum | Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
Genedx Holdings Corp Borsa (WGS) Ultime notizie
GeneDx Breakthrough: How AI Technology is Revolutionizing Genetic Disease Detection - Stock Titan
GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume Dip - Seeking Alpha
GeneDx Holdings Corp (WGS) Shares Up 6.43% on May 16 - GuruFocus
How the (WGS) price action is used to our Advantage - news.stocktradersdaily.com
GeneDx (WGS) Receives Positive Outlook from Guggenheim with Buy Rating | WGS Stock News - GuruFocus
Guggenheim Initiates GeneDx Holdings at Buy With $88 Price Target - marketscreener.com
GeneDx shares tumble 40% after InvestingPro's overvaluation alert By Investing.com - Investing.com South Africa
GeneDx shares tumble 40% after InvestingPro’s overvaluation alert By Investing.com - Investing.com Nigeria
GeneDx: Time To Buy The Dip (NASDAQ:WGS) - Seeking Alpha
GeneDx plunges despite Q1 beat and guidance raise - MSN
GeneDx Holdings stock trades higher as upgraded at Jefferies - MSN
WGS: Key Meeting Announcement by BTIG in San Francisco | WGS Sto - GuruFocus
GeneDx upgraded to Buy from Hold on growth outlook - MSN
GeneDx Shares Rise After Ratings Upgrade From Jefferies - marketscreener.com
GeneDx Holdings (WGS) Upgraded by Jefferies on Growth Prospects - GuruFocus
GeneDx (WGS) Upgraded by Jefferies Amid Growth Prospects - GuruFocus
GeneDx stock upgraded at Jefferies on outlook (WGS:NASDAQ) - Seeking Alpha
Analyst Expectations For GeneDx Holdings's Future - Benzinga
This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga
Jefferies Upgrades GeneDx Holdings (WGS) - Nasdaq
Jefferies Upgrades GeneDx to Buy From Hold, $80 Price Target - marketscreener.com
GeneDx upgraded to Buy from Hold at Jefferies - TipRanks
GeneDx completes acquisition of Fabric Genomics - Yahoo Finance
GeneDx Holdings Corp. completed the acquisition of Fabric Genomics, Inc. - marketscreener.com
GeneDx Holdings Becomes Oversold (WGS) - Nasdaq
GeneDx Announces Completion of Fabric Genomics Acquisition - Business Wire
Envestnet Asset Management Inc. Purchases New Shares in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
Where are the Opportunities in (WGS) - news.stocktradersdaily.com
Best Momentum Stocks to Buy for May 5th - The Globe and Mail
Best Momentum Stocks To Buy For May 5th - Barchart.com
New Strong Buy Stocks for May 5th - Yahoo Finance
Why Investors Were Avoiding GeneDx Holdings Stock This Week - AOL.com
Stamford genetic-testing firm GeneDx still searching for tenants to sublet part of HQ, shuttered CT lab spaces - Hartford Business Journal
With A 26% Price Drop For GeneDx Holdings Corp. (NASDAQ:WGS) You'll Still Get What You Pay For - simplywall.st
GENEDX HOLDINGS (WGS) Upgraded to Buy: Here's Why - MSN
GeneDx Holdings (WGS) Gets a Hold from Wells Fargo - The Globe and Mail
GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates - MSN
GeneDx price target lowered to $78 from $105 at Wells Fargo - TipRanks
GeneDx Holdings (WGS) Receives Adjusted Price Target by Wells Fa - GuruFocus
GeneDx price target lowered to $100 from $115 at BTIG - TipRanks
GeneDx Holdings (WGS) Price Target Lowered by TD Securities | WG - GuruFocus
GeneDx stock target cut to $100 by BTIG, maintains Buy rating - Investing.com Nigeria
GeneDx Holdings (WGS) Receives Adjusted Price Target by Wells Fargo | WGS Stock News - GuruFocus
GeneDx earnings selloff a buying opportunity, says Craig-Hallum - Yahoo Finance
GeneDx (WGS) Price Target Reduced by TD Cowen Amid Strong Perfor - GuruFocus
GeneDx (WGS) Price Target Reduced by TD Cowen Amid Strong Performance | WGS Stock News - GuruFocus
GeneDx (WGS) Stock Decline Seen as Buying Opportunity | WGS Stoc - GuruFocus
GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2025 Earnings Call Transcript - Insider Monkey
GeneDx (WGS) Sees Price Target Cut But Retains Buy Rating | WGS Stock News - GuruFocus
Wells Fargo Adjusts Price Target for GeneDx (WGS) Amid Market Fl - GuruFocus
Genedx Holdings Corp Azioni (WGS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Genedx Holdings Corp Azioni (WGS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Meister Keith A. | Director |
May 08 '25 |
Buy |
56.01 |
100,000 |
5,600,994 |
3,008,629 |
| PFENNIGER RICHARD C JR | Director |
May 02 '25 |
Option Exercise |
0.00 |
918 |
0 |
28,582 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Apr 29 '25 |
Option Exercise |
0.00 |
753 |
0 |
3,725 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Apr 29 '25 |
Sale |
113.09 |
388 |
43,879 |
3,337 |
| Stueland Katherine | Chief Executive Officer |
Apr 29 '25 |
Option Exercise |
0.00 |
3,874 |
0 |
5,594 |
| Stueland Katherine | Chief Executive Officer |
Apr 29 '25 |
Sale |
113.09 |
2,154 |
243,596 |
3,440 |
0.05%
0.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):